Categories AlphaGraphs, Earnings, Health Care
Vertex Pharmaceuticals (VRTX) Earnings: 2Q23 Key Numbers
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported product revenue of $2.49 billion for the second quarter of 2023, which was up 14% year-over-year.
Net income was $915.7 million, or $3.52 per share, compared to $810.5 million, or $3.13 per share, last year. Adjusted EPS was $3.89.
For the full year of 2023, CF product revenues are expected to range between $9.7-9.8 billion.
Prior performance
Most Popular
Infographic: How Deere & Company (DE) performed in Q2 2024
Deere & Company (NYSE: DE) reported second quarter 2024 earnings results today. Total net sales and revenues decreased 12% year-over-year to $15.2 billion. Net income was $2.37 billion, or $8.53
WMT Earnings: Key quarterly highlights from Walmart’s Q1 2025 financial results
Walmart Inc. (NYSE: WMT) reported its first quarter 2025 earnings results today. Consolidated revenue increased 6% year-over-year to $161.5 billion. Revenue growth on a constant currency basis was 5.8%. Consolidated
Home Depot (HD): A look at how the home improvement retailer fared in Q1 2024
Shares of Home Depot (NYSE: HD) rose over 2% on Wednesday. The stock has gained 19% over the past 12 months. The company delivered mixed results for the first quarter